None listed
Conditions
Brief summary
This randomised controlled trial aims to evaluate the effects of marked weight loss, via bariatric surgery, combined with a personalised exercise intervention on markers of brain inflammation. This study will allow us to explore the link between excessive adiposity-induced systemic chronic inflammation, metabolic abnormalities, and neuroinflammation. We hypothesise that bariatric surgery, i.e., marked weight loss, and exercise will result in attenuated neuroinflammation (as measured by neuroimaging), improvements in cognitive function, improvements in immune-inflammatory markers, and improvements in cardiometabolic biomarkers at 12 months compared to control.
Interventions
BARIATRIC SURGERY Eligible participants will undergo either gastric bypass or gastric sleeve surgery. Either surgery results in calorie restriction and significant weight loss (>20% of body weight). The safety and appropriateness of surgery for each candidate will have been determined by health staff. Following surgery, all participants will be reviewed frequently in the acute post-operative phase by health staff and should they become ineligible for the study, this will be communicated to the research team. Provided no complications, the research team will engage with participants during their routine 6-week follow-up to commence the exercise intervention. EXERCISE INTERVENTION: Between weeks 6 and 18, participants will attend a supervised physical activity programme. This programme will be individualised per each participant’s baseline activity and injuries. To measure baseline activity, all participants will wear a Fitbit physical activity tracker for seven continuous days (non-dominant wrist) and will complete a Physical Activity Readiness (PAR) questionnaire prior to their 6-week visit. At this visit, they will also complete a 6-minute walk test, VO2 sub-max test, and undergo a strength assessment with an accredited exercise physiologist (AEP) who will set up a personalised programme. The goal is for participants to work up to the below physical activity goals during the supervised period: (1) At least 150 minutes of moderate-intensity aerobic physical activity per week, 55-70% peak heart rate (monitored via Fitbit), 4-6 on Borg's modified Rating of Perceived Exertion (RPE) scale, involving large muscle groups, over 3 to 5 days per week. (2) Moderate-to-high intensity resistance exercises, 10-15 repetitions of each exercise, 4-6 on Borg's RPE scale, targeting large muscle groups, over 2 to 3 days per week. Aerobic All aerobic sessions will include a 3-minute light intensity warm-up and 2-minute cool down, equivalent to an RPE of 1-3 out of 10.. Aerobic exercises will be done via a treadmill, cycle ergometer, or land based walking as appropriate. Exercise intensity will be individualised from each participant’s percentage of their HRpeak or peak power output as measured during baseline testing. Aerobic exercise intensity will be monitored using the RPE scale and heart rate monitors, i.e., Fitbit. Resistance All strength sessions will be completed with a 5-minute cool down including static stretches and breathing. The resistance program will include 6 to 8 compound exercises focusing on major muscle groups to improve muscle strength and muscle mass such as squats, lunges, modified push-ups, etc. The dosage will include 1 to 3 sets of 8 to 15 repetitions performed at 55-70% of their 1 repetition maximum at baseline, with 1-2-minute rest between sets. The intensity and volume will progressively increase over the course of the 12-week program as tolerated. Technique will be closely monitored, and participants will be encouraged to perform the exercises with control. Participants will attend 2-3 1-hour appointments per week with their AEP. The supervised sessions will be delivered either in an individual setting or in a group of up to three, as needed. Following the supervised period, participants will be given an individualised home based programme and will be monitored via the Fitbit and regular phone follow-up. An option to attend one=to-one 1-hour virtual supervised sessions will be offered. These will be done via an agreed upon video conferencing software, e.g., Zoom or Microsoft Teams. If participants are not meeting exercising as per their programme, they will be contacted using the escalating methods of email, text message or phone calls and will be invited to attend in-person supervised sessions.
Sponsors
Study design
Eligibility
Inclusion criteria
- 18-80 years of age. - Eligible for bariatric surgery. - Willingness to provide informed consent and willingness to participate and comply with the study requirements
Exclusion criteria
- Unable to undertake MRI due to size restrictions i.e., shoulder width more than 70 cm. - History or clinical manifestation of any other significant metabolic, hematologic, pulmonary, cardio- vascular, gastrointestinal, neurologic, immune, hepatic, renal, urologic, muscular, and joint disorders, or cancer that, in the opinion of the investigator, would make the candidate ineligible for the study. For example, significant joint pain could interfere with adherence to the exercise program. - Have objectively assessed cognitive impairment as assessed by the Montreal Cognitive Assessment (MoCA) i.e., total score less than 26. - Non-MRI-compatible implanted devices or implants. - Inability to exercise via supine ergometer. - Claustrophobia. - Psychiatric or behavioural problems (history of drug and alcohol abuse, eating disorder). - Breastfeeding or pregnant women, or those intending to become pregnant before the scheduled end of the intervention. - Unwilling to be assigned at random to the exercise or control intervention. - Unwilling or unable to adhere to the rigors of the exercise intervention or evaluation schedule over the entire one-year period. - Concurrent participation in any other interventional study.